U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Fink HA, Hemmy LS, Linskens EJ, et al. Diagnosis and Treatment of Clinical Alzheimer’s-Type Dementia: A Systematic Review [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 Apr. (Comparative Effectiveness Review, No. 223.)

Cover of Diagnosis and Treatment of Clinical Alzheimer’s-Type Dementia: A Systematic Review

Diagnosis and Treatment of Clinical Alzheimer’s-Type Dementia: A Systematic Review [Internet].

Show details

Appendix BRisk of Bias Assessment Decision Aid

Selection Bias

Definition

Systematic differences between baseline characteristics of the groups that arise from self-selection of treatments, physician-directed selection of treatments, or association of treatment assignments with demographic, clinical, or social characteristics. Good randomization produces study groups that are likely comparable for known and unknown risk factors, removes investigator bias in allocation, and allow the most valid statistical inference in comparing outcomes between groups. In randomized studies, whether there is bias in allocation of study participants to treatment groups is a function both of whether the methods of randomization are good AND whether randomization successfully achieved a balance between treatment groups in risk factors or prognostic covariates.

Assessment Guidance

OPTION 1: The study reports that it was randomized.

Clear Methodology: The study used a randomization method such as random numbers table, computer-generated random number producing algorithm, blocked randomization, stratified randomization, adaptive randomization (e.g., minimization).

Unclear Methodology: Study reports that allocation/assignment was randomized but gives no further detail.

OPTION 2: Study is not randomized (for treatment efficacy outcomes, CCTs are the only eligible nonrandomized study design).

Study uses systematic allocation of treatment by investigator: Systematic and predictable investigator allocation of treatment assignment (e.g., alternation, based on day of week, based on the month of birthday).

Study should use an appropriate statistical adjustment (propensity score, instrumental variable, multivariate).

Figure B.1 shows decision options for selection bias.

Appendix Table B.1 describes the selection bias assessment guidance used to determine risk of bias for eligible studies.

Figure B.1Selection bias assessment guidance

Attrition

Definition

Loss of participants from the study, potential systematic differences in that loss to follow-up, and how losses were accounted for in the results (e.g., incomplete follow-up, differential attrition). Those who drop out of the study or who are lost to follow-up may be systematically different from those who remain in the study. Attrition bias can potentially change the collective (group) characteristics of the relevant groups and their observed outcomes in ways that affect study results by confounding and spurious associations. Overall attrition refers to attrition in all groups combined for a given outcome comparison and timepoint. Differential attrition refers to the absolute difference between groups in attrition for a given outcome comparison and timepoint.

Assessment Guidance

*Studies that have long-term outcomes that are 5 years and longer should be assessed on a case-by-case basis.

OPTION 1: Study has low overall attrition (<10%). Reasons for incomplete/missing data should be adequately explained.

OPTION 2: Study has moderate overall attrition (10 to 20%). Reasons for incomplete/missing data should be adequately explained and authors should attempt to address attrition in their analysis. Analysis should be done with appropriate method, noting that this may help explain the size and direction of the potential bias, but they don’t eliminate the bias. Last valued carried forward is not an appropriate adjustment. Some imputation methods might be appropriate (to be evaluated on a case-by-case basis).

OPTION 3: Study has high overall attrition (>20 to 30%) Reasons for incomplete/missing data should be adequately explained and authors should to address attrition in their analysis with an appropriate method. This reduces, but does not eliminate, the risk of attrition bias. Last valued carried forward is not an appropriate adjustment. Some imputation methods might be appropriate (to be evaluated on a case-by-case basis).

OPTION 4: Study has very high overall attrition (>30%) Authors may attempt to address attrition in their analysis, but the risk of attrition bias is high.

OPTION 5: Reporting of attrition by study arm is inadequate. It is unclear how many participants have been lost in each group. Risk of attrition bias is high.

Figure B.2 shows decision options for attrition bias.

Appendix Table B.2 describes the attrition assessment guidance used to determine risk of bias for eligible studies.

Figure B.2Attrition assessment guidance

Performance Bias

Definition

Systematic differences in the care provided to participants and protocol deviation. Examples include contamination of the control group with the exposure or intervention, unbalanced provision of additional interventions or co-interventions, difference in co-interventions, and inadequate blinding of providers and participants. Intention-to-Treat Principle (ITT) is when the study counts events in all randomized participants according to their treatment assignment, regardless of whether they received assigned treatment. It does not exclude participants from analysis for nonadherence, protocol deviations, withdrawal, or anything else that happens after randomization. To exclude such participants undercuts the benefit of randomization in minimizing selection bias. Modified ITT (mITT) is where analyses exclude randomized participants who did not receive any of their assigned treatment. This is not strictly ITT, but is accepted as such by the FDA in evaluating drug trials for approval.

Assessment Guidance

Guidelines for assessing performance bias are detailed in Appendix Tables B.1 and B.2.

Appendix Table B.1Assessment guidance for performance bias

DomainAssessmentOptions
1. ITT/Adjustment of Known ConfoundersOPTION 1A: Study is an RCT. Check if study uses ITT or modified ITT.
-

Yes

-

No

-

Unclear/Not Reported

OPTION 1B: Study is a CCT. Check for adjustment of known confounders.

Adequate adjustment includes adjustment for at least age, sex, and baseline cognition.

Partially adequate adjustment adjusts for 1 or 2 of these potential confounder categories.

Inadequate adjustment does not adjust for any of these potential confounder categories.

-

Adequate

-

Partially Adequate

-

Inadequate

2. Participant BlindingFor all studies, check to see if participant blinding is described in text.Yes
No
Unclear

Appendix Table B.2Overall performance rating for performance bias assessment

Overall Performance RatingLow = ITT or adequate adjustment of confounders. Participants are blinded.Medium = Unclear ITT or partially adequate adjustment of confounders. Participant blinding is unclear or not described.High = No ITT or inadequate adjustment of known confounders.

Detection Bias

Definition

Systematic differences in outcomes assessment among groups being compared, including systematic misclassification of the exposure or intervention, covariates, or outcomes because of variable definitions and timings, diagnostic thresholds, recall from memory, inadequate assessor blinding, and faulty measurement techniques. Erroneous statistical analysis might also affect the validity of effect estimates.

Assessment Guidance

Guidelines for assessing detection bias are detailed in Appendix Tables B.3 and B.4.

Appendix Table B.3Assessment guidance for detection bias

AssessmentOptions
1. Check if outcome assessors were blinded to treatment assignment.
-

Yes

-

No

-

Unclear

2. Check if studies used validated, reliable, outcomes measure and that the groups assessed using comparable outcome measures. Please flag the test for the team if you are unsure if a test is validated or think that the measure is based on unconfirmed self-report.
-

Yes

-

No

-

Unclear

Appendix Table B.4Overall performance rating for detection bias assessment

Overall Performance RatingLow = 2 Yes OR 1 Yes, 1 UnclearMedium = All unclearHigh = At least 1 No

Reporting Bias

Definition

Systematic differences between reported and unreported findings (e.g., differential reporting of outcomes or harms, incomplete reporting of study findings). Reporting bias includes selective analysis (e.g., study combines intervention groups or adjusts planned analysis without explanation).

Assessment Guidance

  • Check if all outcomes reported in the methods section reported in the result section and vice versa (Appendix Table B.5).
  • If study indicates that additional information is available in a separate protocol, protocol papers should be checked to ensure no relevant information is missed.

Appendix Table B.5Assessment guidance for reporting bias

AssessmentOptionsRating
Check if all outcomes are reported without selective analysis?YesLow
NoHigh
UnclearMedium

Overall Risk of Bias Assessment

Assessment Guidance

Overall risk of bias is determined by reviewer, or team, consensus. Figure B.3 provides a guide for how to rate overall risk of bias, based on the assessment of each individual domain. Reviewers should use this guide when making judgements about overall risk of bias. However, there may be cases where deviation from this guide is necessary and appropriate. For clarification and transparency, reviewers should provide a brief written justification for these deviations.

Figure B.3 describes the overall risk of bias assessment process for eligible studies.

Figure B.3Overall risk of bias assessment guidance

Views

Other titles in this collection

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...